title: Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
abstract: Cancer genomic DNA sequences enable identification of all mutations and suggest targets for precision medicine. The identities and patterns of the mutations themselves also provide critical information for deducing the originating DNA damaging agents, causal molecular mechanisms, and thus additional therapeutic targets. A classic example is ultraviolet light, which crosslinks adjacent pyrimidines and leads to C-to-T transitions. A new example is the DNA cytosine deaminase APOBEC3B, which was identified recently as a source of DNA damage and mutagenesis in breast, head/neck, cervix, bladder, lung, ovary, and to lesser extents additional cancer types. This enzyme is normally an effector protein in the innate immune response to virus infection but upregulation in these cancer types causes elevated levels of genomic C-to-U deamination events, which manifest as C-to-T transitions and C-to-G transversions within distinct DNA trinucleotide contexts (preferentially 5'-TCA and 5'-TCG). Genomic C-to-U deamination events within the same trinucleotide contexts also lead to cytosine mutation clusters (kataegis), and may precipitate visible chromosomal aberrations such as translocations. Clinical studies indicate that APOBEC3B upregulation correlates with poorer outcomes for estrogen receptor-positive breast cancer patients, including shorter durations of disease-free survival and overall survival after surgery. APOBEC3B may therefore have both diagnostic and prognostic potential. APOBEC3B may also be a candidate for therapeutic targeting because inhibition of this non-essential enzyme is predicted to decrease tumor mutation rates and diminish the likelihood of undesirable mutation-dependent outcomes such as recurrence, metastasis, and the development of therapy resistant tumors.
authors.forename: Reuben S
authors.initials: RS
authors.lastname: Harris
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D002384:Catalysis; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism; D003564:Cytidine Deaminase / Q000235:genetics / Q000378:metabolism*; D004249:DNA Damage; D018450:Disease Progression; D005260:Female; D006801:Humans; D015994:Incidence; D015778:Minor Histocompatibility Antigens; D005810:Multigene Family; D016296:Mutagenesis / Q000528:radiation effects; D009154:Mutation
chemical_list: D015778:Minor Histocompatibility Antigens; C495794:APOBEC3B protein, human; D003564:Cytidine Deaminase
references.citation: MBio. 2014;5(6). pii: e02234-14. doi: 10.1128/mBio.02234-14
references.pmid: 25538195
references.citation: Nat Commun. 2014;5:5129
references.pmid: 25298230
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8483-7
references.pmid: 7667315
references.citation: Nature. 2013 Feb 21;494(7437):366-70
references.pmid: 23389445
references.citation: Science. 2014 Mar 28;343(6178):1470-5
references.pmid: 24675954
references.citation: Front Genet. 2012 Sep 06;3:174
references.pmid: 22973298
references.citation: Annu Rev Biochem. 2007;76:1-22
references.pmid: 17328676
references.citation: Elife. 2013;2:e00534
references.pmid: 23599896
references.citation: Mol Cell. 2012 May 25;46(4):424-35
references.pmid: 22607975
references.citation: J Biol Chem. 2012 Oct 5;287(41):34801-8
references.pmid: 22896697
references.citation: Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18219-24
references.pmid: 19822754
references.citation: Elife. 2014;3:e02001
references.pmid: 24843013
references.citation: Int J Cancer. 2012 Dec 15;131(12):2724-32
references.pmid: 22945513
references.citation: Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9854-9
references.pmid: 16000409
references.citation: Nature. 2012 Jun 21;486(7403):400-4
references.pmid: 22722201
references.citation: PLoS One. 2013;8(8):e73641
references.pmid: 23977391
references.citation: Science. 2014 Mar 28;343(6178):1466-70
references.pmid: 24675953
references.citation: ChemMedChem. 2013 Jan;8(1):112-7
references.pmid: 23180603
references.citation: Expert Rev Anticancer Ther. 2012 Aug;12(8):1021-32
references.pmid: 23030222
references.citation: J Mol Biol. 2004 Mar 26;337(3):585-96
references.pmid: 15019779
references.citation: Biosci Rep. 1986 Apr;6(4):387-93
references.pmid: 3527293
references.citation: Cell. 2012 May 25;149(5):994-1007
references.pmid: 22608083
references.citation: Nature. 2014 Mar 20;507(7492):315-22
references.pmid: 24476821
references.citation: BMC Med Genomics. 2014;7:11
references.pmid: 24552141
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: J Biol Chem. 2003 May 30;278(22):19583-6
references.pmid: 12697753
references.citation: Science. 2007 Nov 16;318(5853):1108-13
references.pmid: 17932254
references.citation: Genome Res. 2013 Feb;23(2):228-35
references.pmid: 23124520
references.citation: Nat Struct Mol Biol. 2010 Feb;17(2):222-9
references.pmid: 20062055
references.citation: Science. 2006 Oct 13;314(5797):268-74
references.pmid: 16959974
references.citation: Nature. 2013 Jul 11;499(7457):214-8
references.pmid: 23770567
references.citation: Curr Top Microbiol Immunol. 2013;371:1-27
references.pmid: 23686230
references.citation: Nature. 2013 Jan 17;493(7432):356-63
references.pmid: 23325218
references.citation: Cell Rep. 2014 Jun 26;7(6):1833-41
references.pmid: 24910434
references.citation: Int J Oncol. 2008 Aug;33(2):261-70
references.pmid: 18636146
references.citation: Front Microbiol. 2013 Feb 20;4:28
references.pmid: 23431045
references.citation: Nat Genet. 2013 Sep;45(9):977-83
references.pmid: 23852168
references.citation: Nature. 2002 Jul 4;418(6893):99-103
references.pmid: 12097915
references.citation: Horm Cancer. 2014 Dec;5(6):405-13
references.pmid: 25123150
references.citation: J Biol Chem. 2003 Jan 17;278(3):1395-8
references.pmid: 12446660
references.citation: Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4858-63
references.pmid: 21368204
references.citation: Nat Struct Mol Biol. 2011 Feb;18(2):230-6
references.pmid: 21258325
references.citation: Annu Rev Pathol. 2013 Jan 24;8:79-103
references.pmid: 22974238
references.citation: DNA Repair (Amst). 2013 Nov;12(11):878-89
references.pmid: 23988736
references.citation: ACS Chem Biol. 2012 Mar 16;7(3):506-17
references.pmid: 22181350
references.citation: Nature. 2013 Aug 22;500(7463):415-21
references.pmid: 23945592
references.citation: Cell. 2012 May 25;149(5):979-93
references.pmid: 22608084
references.citation: PLoS One. 2014;9(5):e97787
references.pmid: 24858917
references.citation: J Biol Chem. 2012 Nov 9;287(46):39182-92
references.pmid: 22977230
references.citation: Mol Cell. 2002 Nov;10(5):962-3
references.pmid: 12453402
references.citation: Nature. 2012 Oct 4;490(7418):61-70
references.pmid: 23000897
references.citation: EMBO Rep. 2011 May;12(5):444-50
references.pmid: 21460793
references.citation: J Biol Chem. 2013 Jun 14;288(24):17253-60
references.pmid: 23640892
references.citation: PLoS Genet. 2007 Apr 20;3(4):e63
references.pmid: 17447845
references.citation: Nat Genet. 2014 May;46(5):487-91
references.pmid: 24728294
references.citation: Genome Biol. 2014;15(7):417
references.pmid: 25085003
references.citation: Carcinogenesis. 2013 Oct;34(10):2240-3
references.pmid: 23715497
references.citation: Science. 2013 Mar 29;339(6127):1546-58
references.pmid: 23539594
references.citation: Front Biosci. 2002 Apr 1;7:d1024-43
references.pmid: 11897551
references.citation: PLoS Genet. 2012;8(12):e1003149
references.pmid: 23271983
references.citation: Mol Cell. 2002 Nov;10(5):1247-53
references.pmid: 12453430
references.citation: Biochemistry. 2010 Jun 22;49(24):4957-67
references.pmid: 20469926
references.citation: Nat Genet. 2005 Jun;37(6):590-2
references.pmid: 15908952
references.citation: Cancer Res. 2013 Dec 15;73(24):7222-31
references.pmid: 24154874
references.citation: Cold Spring Harb Perspect Med. 2012 May;2(5):a006940
references.pmid: 22553496
references.citation: Nat Genet. 2013 Sep;45(9):970-6
references.pmid: 23852170
references.citation: DNA Repair (Amst). 2011 Jul 15;10(7):730-3
references.pmid: 21601536
references.citation: Genes (Basel). 2014 Mar 05;5(1):108-46
references.pmid: 24705290
references.citation: Elife. 2013;2:e01222
references.pmid: 24171103
references.citation: Genome Res. 2012 Dec;22(12):2328-38
references.pmid: 22968929
references.citation: Crit Rev Oncog. 2008;14(1):1-22; discussion 23-31
references.pmid: 19105568
references.citation: J Natl Cancer Inst. 2013 Apr 17;105(8):573-9
references.pmid: 23411593